teach robotic platforms, recover platforms when they malfunction and configure complex cellular readers, to prevent any costly delays to the drug discovery pipeline.” Charles River’s team of experts provides critical

support for automated solutions throughout the drug discovery and development pipeline, from hit identification through to the pre-clinical phases. Similarly, Promega’s team of Global Field Services Scientists will collaborate with customers on-site to optimise and programme assays for high- throughput platforms.

What’s the future of cell-based automation in drug discovery? Ongoing advances in automated cell-based assays are likely to focus on a variety of existing needs in drug discovery. One such need is for modular devices that can quickly adapt to new laboratory conditions and devices, as well as formore compact systems to enable them to fit into increasingly lim- ited laboratory spaces. Moreover, it is likely that improvements in software will continue to drive data analyses as well as data trending to provide greater analysis capabilities. With every laboratory looking to reduce costs, there will also be continued demand for scalable automated systems that can quickly increase throughput, as well as label-free applications such as matrix-assisted laser desorp- tion/ionisation (often referred to asMALDI),which avoid the use of expensive fluorescence markers. “As automation technologies become more col-

laborative, intuitive and versatile,more researchers will be able to access these tools for cellular assays,” says Dara Grantham Wright, Vice- President and General Manager, Protein and Cell Analysis Business Unit, Life Science Solutions Group, Thermo Fisher Scientific. “This will improve our ability to develop more clinically-rel- evantmodels and enhance the overall reproducibil- ity of data, helping to discover new drug classes, personalised treatments and replace conventional animal testing.” As researchers explore more complex disease

types and employ co-culture systems, it is also like- ly that the resurgence of phenotypic and fragment- based screening will continue. In addition, the combination of cell biology with virtual simula- tions and computer learning is set to further advance cellular assays in drug discovery.

Conclusion Automation is enabling more sophisticated cell- based assays to advance drug discovery. Laboratories can gain numerous benefits from

Drug DiscoveryWorld Summer 2019 29

How public relations can maximise results from your next tradeshow

By Helen Stewart-Miller,Director of PR Services,BioStrata T

radeshows offer valuable opportunities to connect with a large, rele- vant audience of customers, prospects, distributors and media con- tacts – whether your company is a start-up or a global corporation.

While exhibiting requires substantial investment, from booth costs to time committed by personnel attending the event, public relations (PR) connects you with life science media to improve your company’s visibility and coverage in publications read by attendees and non-attendees. An effective PR strategy can be designed to engage media by harnessing a

strong news hook, such as a product launch or a significant company announcement; positioning your company as credible thought-leaders with valuable industry insight; or combining these approaches. Depending on which you choose, here are three steps to consider before your next tradeshow: Identify relevant publications: The life science media sector is ever-changing and complex, so it is crucial to target the right publications. Ahead of a press release distribution, you will want to consider which editors will find your news interesting and want to share it with their readers. For planning media engagement around the tradeshow, prioritise the most influential and relevant editors and reporters, and then identify who will actually be attending. Prepare a compelling press release: A press release remains one of the most effective ways to enable publications to report your news easily and accurately. Include the show details and your booth number, as well as any sessions, work- shops or posters you have planned. Arrange on-booth media meetings and demonstrations: These conversations bring your news to life, offer valuable industry insight and may identify oppor- tunities for contributing editorial features. You will need to plan ahead to secure time with editors – their schedules get booked up fast. The tacticalmix included as part of a PR strategy canmake themost of every

moment – before, during and after an event. If you want to learn more about how to maximise your company’s next tradeshow, book a conversation today with our PR specialists by visiting

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64